Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07806266) titled 'EORTC Metastatic Breast Cancer Module Development' on Sept. 2.
Study Type: Observational
Primary Sponsor: University of Leeds
Condition:
Metastatic Beast Cancer
Recruitment Status: Recruiting
Date of First Enrollment: May 1, 2020
Target Sample Size: 568
Countries of Recruitment:
Belgium
Canada
France
Germany
India
Italy
Japan
Jordan
Netherlands
Poland
Portugal
Slovakia
Spain
United Kingdom
Belgium
Canada
France
Germany
India
Italy
Japan
Jordan
Netherlands
Poland
Portugal
Slovakia
Spain
United Kingdom
To know more, visit https://clinicaltrials.gov/study/NCT07806266
Disclaimer: Curated by HT Syndication....